446 related articles for article (PubMed ID: 28027898)
1. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
2. The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.
Belinova L; Kahleova H; Malinska H; Topolcan O; Windrichova J; Oliyarnyk O; Kazdova L; Hill M; Pelikanova T
PLoS One; 2017; 12(4):e0174820. PubMed ID: 28369078
[TBL] [Abstract][Full Text] [Related]
3. Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.
Chowdhury S; Wang S; Dunai J; Kilpatrick R; Oestricker LZ; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
PLoS One; 2016; 11(6):e0156852. PubMed ID: 27304975
[TBL] [Abstract][Full Text] [Related]
4. Circulating concentrations of glucagon-like peptide 1, glucose-dependent insulinotropic peptide, peptide YY, and insulin in client-owned lean, overweight, and diabetic cats.
McMillan CJ; Zapata RC; Chelikani PK; Snead EC; Cosford K
Domest Anim Endocrinol; 2016 Jan; 54():85-94. PubMed ID: 26609567
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
6. Postprandial Effects of Blueberry (
Stote K; Corkum A; Sweeney M; Shakerley N; Kean T; Gottschall-Pass K
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30669469
[TBL] [Abstract][Full Text] [Related]
7. Gastrointestinal motility in patients with end-stage renal disease on chronic hemodialysis.
Broberg B; Madsen JL; Fuglsang S; Holst JJ; Christensen KB; Rydahl C; Idorn T; Feldt-Rasmussen B; Hornum M
Neurogastroenterol Motil; 2019 Apr; 31(4):e13554. PubMed ID: 30667131
[TBL] [Abstract][Full Text] [Related]
8. The combination of GIP plus xenin-25 indirectly increases pancreatic polypeptide release in humans with and without type 2 diabetes mellitus.
Chowdhury S; Wang S; Patterson BW; Reeds DN; Wice BM
Regul Pept; 2013 Nov; 187():42-50. PubMed ID: 24183983
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects.
Haluzíková D; Lacinová Z; Kaválková P; Drápalová J; Křížová J; Bártlová M; Mráz M; Petr T; Vítek L; Kasalický M; Haluzík M
Obesity (Silver Spring); 2013 Jul; 21(7):1335-42. PubMed ID: 23670968
[TBL] [Abstract][Full Text] [Related]
10. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients.
Toft-Nielsen MB; Damholt MB; Madsbad S; Hilsted LM; Hughes TE; Michelsen BK; Holst JJ
J Clin Endocrinol Metab; 2001 Aug; 86(8):3717-23. PubMed ID: 11502801
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y and peptide YY, but not pancreatic polypeptide, substance P, cholecystokinin and gastric inhibitory polypeptide, inhibit the glucagon- and noradrenaline-dependent increase in glucose output in rat liver.
Lüers C; Gardemann A; Miura H; Jungermann K
Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):455-62. PubMed ID: 10784001
[TBL] [Abstract][Full Text] [Related]
12. Incretins, amylin and other gut-brain axis hormones in children with coeliac disease.
Papastamataki M; Papassotiriou I; Bartzeliotou A; Vazeou A; Roma E; Chrousos GP; Kanaka-Gantenbein C
Eur J Clin Invest; 2014 Jan; 44(1):74-82. PubMed ID: 24151959
[TBL] [Abstract][Full Text] [Related]
13. The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose tolerance.
Marathe CS; Pham H; Marathe JA; Trahair LG; Huynh L; Wu T; Phillips LK; Rayner CK; Nauck MA; Horowitz M; Jones KL
Acta Diabetol; 2020 May; 57(5):583-587. PubMed ID: 31848710
[TBL] [Abstract][Full Text] [Related]
14. GIP contributes to islet trihormonal abnormalities in type 2 diabetes.
Chia CW; Odetunde JO; Kim W; Carlson OD; Ferrucci L; Egan JM
J Clin Endocrinol Metab; 2014 Jul; 99(7):2477-85. PubMed ID: 24712564
[TBL] [Abstract][Full Text] [Related]
15. Expected values for gastrointestinal and pancreatic hormone concentrations in healthy volunteers in the fasting and postprandial state.
Meek CL; Lewis HB; Burling K; Reimann F; Gribble F
Ann Clin Biochem; 2021 Mar; 58(2):108-116. PubMed ID: 33175577
[TBL] [Abstract][Full Text] [Related]
16. Short-term glucose metabolism and gut hormone modulations after Billroth II gastrojejunostomy in nonobese gastric cancer patients with type 2 diabetes mellitus, impaired glucose tolerance and normal glucose tolerance.
Zhang XJ; Xiao Z; Yu HL; Zhang XX; Cheng Z; Tian HM
Arch Med Res; 2013 Aug; 44(6):437-43. PubMed ID: 23973197
[TBL] [Abstract][Full Text] [Related]
17. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal Changes in Fasting and Glucose-Stimulated GLP-1 and GIP in Healthy Older Subjects.
Pham H; Marathe CS; Phillips LK; Trahair LG; Hatzinikolas S; Huynh L; Wu T; Nauck MA; Rayner CK; Horowitz M; Jones KL
J Clin Endocrinol Metab; 2019 Dec; 104(12):6201-6206. PubMed ID: 31393567
[TBL] [Abstract][Full Text] [Related]
19. Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication.
Miholic J; Hoffmann M; Holst JJ; Lenglinger J; Mittlböck M; Bergmann H; Stacher G
Surg Endosc; 2007 Feb; 21(2):309-14. PubMed ID: 17200910
[TBL] [Abstract][Full Text] [Related]
20. Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.
Veedfald S; Vedtofte L; Skov-Jeppesen K; Deacon CF; Hartmann B; Vilsbøll T; Knop FK; Christensen MB; Holst JJ
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31665480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
